Transseptal vs. Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli Multi-center comparative effectiveness randomized clinical trial to assess a transeptal approach to left ventricular ablation compared to a retrograd aortic aproach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tacht=ycardia (VT) and /or premature ventricular contractions (PVCs)

Recruiting
99 years or below
All
12 participants needed
1 Location

Brief description of study

Both transseptal and retrograde aortic approaches are routinely utilized in pediatric and adult cardiac electrophysiology and cardiac catheterization laboratories in the United States and have been in clinical practice for decades to treat multiple types of left atrial and ventricular arrhythmias. As either approach can be used to perform catheter ablation of ventricular tachycardia (VT) and premature ventricular contractions (PVCs), the decision is currently based on physician preference driven primarily by anecdote and personal experience.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All
Updated on 14 Oct 2020. Study ID: 834089

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center